Hypoglycemic Agents: all 3,927 studies that test it
Page 38 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin ExcretionCompletedNCT00238472Phase 4
- A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in ChildrenCompletedNCT00237302Phase 3
- Topiramate Versus Placebo as add-on Treatment in Patients With Bipolar Disorder in the Outpatient SettingCompletedNCT00237289Phase 3
- Efficacy and Safety of Vildagliptin in Subjects With Impaired Glucose ToleranceCompletedNCT00237250Phase 3
- Vildagliptin Compared to Pioglitazone in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT00237237Phase 3
- Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy PatientsCompletedNCT00236886Phase 3
- A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.CompletedNCT00236873Phase 2
- A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset SeizuresCompletedNCT00236860Phase 2
- A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.CompletedNCT00236847Phase 2
- A Study of the Efficacy and Safety of Topiramate as an add-on Therapy in the Treatment of Epilepsy Patients With Lennox-Gastaut SyndromeCompletedNCT00236756Phase 3
- A Study of the Effectiveness and Safety of Topiramate in the Treatment of Children With EpilepsyCompletedNCT00236743Phase 3
- A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Difficult to Control EpilepsyCompletedNCT00236730Phase 2
- A Study of the Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With EpilepsyCompletedNCT00236717Phase 3
- A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresCompletedNCT00236704Phase 3
- A Study of the Efficacy and Safety of Topiramate as add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-onset Seizures.CompletedNCT00236691Phase 2
- A Study of Efficacy and Safety of Topiramate in the Treatment of Obese Patients With Mild to Moderate Essential HypertensionCompletedNCT00236665Phase 3
- A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With ObesityCompletedNCT00236639Phase 3
- A Study of the Safety and Effectiveness of Topiramate on Insulin Sensitivity in Overweight or Obese Patients With Type 2 DiabetesCompletedNCT00236626Phase 2
- A Study on Efficacy and Safety of Topiramate in the Treatment of Patients With ObesityCompletedNCT00236613Phase 2
- A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss ProgramCompletedNCT00236600Phase 3
- A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of MigraineCompletedNCT00236561Phase 3
- A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCompletedNCT00236509Phase 3
- A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Treating Tremor of Unknown Cause.CompletedNCT00236496Phase 3
- A Study of the Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresCompletedNCT00236418Phase 3
- A Study of the Pharmacokinetics, Safety and Tolerability of Topiramate in Infants (Age 1-24 Months) With Refractory Partial-onset SeizuresCompletedNCT00233012Phase 1
- Intervention to Preserve Beta-Cell Function in GAD Ab-Positive DiabetesCompletedNCT00232375Not applicable
- Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes MellitusWithdrawnNCT00232362Phase 1
- A Study To Evaluate The Effect Of Topiramate On Clinical And Electrophysiological Parameters In Subjects With Diabetic Peripheral PolyneuropathyCompletedNCT00231673Phase 2
- A Study of the Efficacy and Safety of Topiramate in the Treatment fo Obese, Type 2 Diabetic Patients Treated With MetforminCompletedNCT00231660Phase 3
- A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or MetforminCompletedNCT00231647Phase 2
- A Study of the Efficacy and Safety of Topiramate in Obese, Type 2 Diabetic Patients Inadequately Controlled on Sulfonylurea TherapyTerminatedNCT00231634Phase 3
- A Study on Efficacy and Safety of Topiramate in Treatment of Obese Subjects With DyslipidemiaTerminatedNCT00231621Phase 3
- A Study of Safety and Efficacy of Topiramate in Male Patients With Abdominal ObesityCompletedNCT00231608Phase 2
- A Study of the Efficacy and Safety of Topiramate in the Prevention of MigraineCompletedNCT00231595Phase 3
- A Study on Safety and Efficacy of Two Doses of Topiramate as Monotherapy in the Treatment of Newly Diagnosed or Recurrent EpilepsyCompletedNCT00231556Phase 3
- A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled DietCompletedNCT00231530Phase 3
- Rosiglitazone And Plaque Study for Type 2 Diabetes MellitusCompletedNCT00231387Phase 3
- Repaglinide for Adolescents With Cystic Fibrosis-Related DiabetesWithdrawnNCT00231192Not applicable
- A Study of the Effectiveness and Safety of Topiramate Monotherapy in Patients With Recently Diagnosed Partial-Onset SeizureCompletedNCT00230698Phase 3
- Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)CompletedNCT00227110Phase 4
- GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes MellitusTerminatedNCT00226330Phase 3
- Rosiglitazone Versus Placebo in Chronic Stable AnginaTerminatedNCT00225355Phase 4
- Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With AnginaWithdrawnNCT00225342Phase 4
- Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.CompletedNCT00225264Phase 3
- New Medications to Treat Alcohol DependenceCompletedNCT00223639Phase 2
- Topiramate to Reduce Cocaine DependenceCompletedNCT00223626Phase 2
- Insulin Glargine Vs Standard Insulin TherapyCompletedNCT00222521Phase 3
- A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple SclerosisStatus unknownNCT00217295Phase 2
- The Prolonged Use of Topiramate for Preventing Migraine HeadachesCompletedNCT00216619Phase 3
- The Effectiveness and Safety of Topiramate on Prevention of Chronic MigraineCompletedNCT00216606Phase 3
- Safety and Efficacy of Topamax Versus Carbamazepine in Benign Rolandic EpilepsyCompletedNCT00216567Phase 4
- Islet Transplantation in Type 1 Diabetic PatientsCompletedNCT00214253Phase 1
- Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With InsulinCompletedNCT00213122Phase 3
- Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin TreatmentCompletedNCT00213109Phase 3
- Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin TreatmentCompletedNCT00213070Phase 3
- Evaluation of the Effectiveness of Topiramate in Preventing the Transformation From Episodic Migraine to Chronic Daily Headache.CompletedNCT00212810Phase 4
- Assessment of an Alpha-glucosidase Inhibitor to Block Cardiac Events in Patients With MI and IGTTerminatedNCT00212017Not applicable
- Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)TerminatedNCT00212004Phase 4
- Topiramate Augmentation in the Treatment of Obsessive-Compulsive DisorderCompletedNCT00211744Phase 4
- An Efficacy and Safety Study of Topiramate in the Treatment of Alcohol DependenceCompletedNCT00210925Phase 2
- A Study of the Effectiveness and Safety of Topiramate Versus Placebo for Preventing Chronic Migraine HeadachesCompletedNCT00210912Phase 3
- An Open Label Extension of a Study of Topiramate in Chronic Migraine.CompletedNCT00210873Phase 3
- An Open Label Extension of a Study Comparing Topiramate and Amitriptyline in Migraine Prevention.CompletedNCT00210860Phase 3
- Comparing the Safety and Effectiveness of Topiramate With the Safety and Effectiveness of Amitriptyline in Preventing Migraine HeadachesCompletedNCT00210821Phase 3
- A Study of the Effectiveness and Safety of Topiramate in the Treatment of Moderate to Severe Binge-eating Disorder Associated With ObesityCompletedNCT00210808Phase 2/3
- A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug TreatmentCompletedNCT00210782Phase 3
- A Pilot Study of Topiramate in Childhood Absence EpilepsyCompletedNCT00210574Phase 2
- Potential Impact (Benefit) of Preventative Treatment With Topamax on the Effectiveness of Axert in the Acute Treatment of MigraineCompletedNCT00210496Phase 4
- Glaser Obesity StudyStatus unknownNCT00209482Phase 2/3
- A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine CravingCompletedNCT00208858Phase 2
- Topiramate in the Treatment of Posttraumatic Stress Disorder in CiviliansCompletedNCT00208130Phase 4
- Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and RibavirinCompletedNCT00207402Phase 4
- The Effect of Prolonged Pramlintide Infusion in Pediatric DiabetesCompletedNCT00206297Phase 3
- The Role of Amylin and Glucagon in T1DMCompletedNCT00206258Phase 3
- Safety & Efficacy Study Using Topiramate in Posttraumatic Stress DisorderCompletedNCT00204386Phase 2/3
- Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)CompletedNCT00203463Phase 4
- A Double-Blind, Placebo-Controlled Study Examining the Use of Topiramate in the Treatment of Cluster HeadacheTerminatedNCT00203190Phase 4
- Efficacy and Safety Study of Topiramate to Treat Restless Legs SyndromeCompletedNCT00200941Phase 4
- Study In Patients With Insulin ResistanceCompletedNCT00197132Phase 3
- Pilot Studies of Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis (FSGS)CompletedNCT00193648Phase 1
- Local Registration Trial in China Humalog Mix 50CompletedNCT00191581Phase 3
- Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 DiabetesCompletedNCT00191464Phase 4
- Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 DiabetesCompletedNCT00191178Phase 4
- Nateglinide: a Double Blind Add-on Study With Pioglitazone for Type 2 Diabetic PatientsCompletedNCT00189774Phase 2/3
- A Study to Examine the Long Term Effect of Pramlintide on Body Weight and Its Safety and Tolerability in Obese SubjectsCompletedNCT00189514Phase 2
- Pioglitazone in Hepatitis CCompletedNCT00189163Phase 4
- Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive DisorderCompletedNCT00187928Phase 3
- Impact of Genetics on Metformin PharmacokineticsCompletedNCT00187798Not applicable
- Comparison of Insulin Detemir With NPH Insulin in Type 1 DiabetesCompletedNCT00184665Phase 3
- Comparison of Insulin Detemir and Insulin Semilente®MC in Type 1 DiabetesCompletedNCT00184639Phase 3
- Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.CompletedNCT00184626Phase 4
- Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 DiabetesCompletedNCT00184613Phase 1
- Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 DiabetesCompletedNCT00184574Phase 3
- Effectiveness and Safety of Biphasic Insulin Aspart 70/30 in Subjects With Type 2 DiabetesCompletedNCT00184561Phase 4
- Efficacy of Adding Topiramate to Current Treatment in Refractory Obsessive Compulsive Disorder (OCD)CompletedNCT00182520Phase 4
- Efficacy of Adding Topiramate to Current Treatment in Treatment-Resistant Generalized Social Phobia (GSP)TerminatedNCT00182455Phase 4
- Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate CancerCompletedNCT00182052Phase 3
- Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 DiabetesCompletedNCT00174993Phase 3
- Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic PatientsCompletedNCT00174824Phase 4
- Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 DiabetesCompletedNCT00174681Phase 4